Irenix Medical, Inc.
Medtech · Acquired
IRX-101, a novel non-toxic ocular antiseptic molecule for intravitreal injection procedures
- Grants
- $7.1M
- 9 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 21
- 0 granted · 21 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · A Novel Device for Ultra-Rapid Non-Pharmacologic Ocular Anesthesia | $581,104 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Device for Ultra-Rapid Non-Pharmacologic Ocular Anesthesia | $2,539,215 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Device for Ultra-Rapid Non-Pharmacologic Ocular Anesthesia | $859,036 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Device for Ultra-Rapid Non-Pharmacologic Ocular Anesthesia | $247,170 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel, Non-Toxic Ocular Antiseptic For Intravitreal Injection Therapy | $847,954 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Device for Ultra-Rapid Non-Pharmacologic Ocular Anesthesia | $88,810 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel, Non-Toxic Ocular Antiseptic For Intravitreal Injection Therapy | $897,021 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel, Non-Toxic Ocular Antiseptic For Intravitreal Injection Therapy | $793,154 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel, Non-Toxic Ocular Antiseptic For Intravitreal Injection Therapy | $223,095 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1839 | ENDOPROTECH, INC. | — | — |
| 1840 | SUBTLE MEDICAL, INC. | — | — |
| 1841 | Enable Biosciences Inc. | — | — |
| 1842 | Irenix Medical, Inc. | — | — |
| 1843 | CORAMIR BIOMEDICAL, INC. | — | — |
| 1844 | BMSEED, LLC | — | — |
| 1845 | SIL Technologies LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Sodium Chlorite Compositions with Enhanced Anti-Viral and Anti-Microbial Efficacy and Reduced Toxicityapplication
- Sodium Chlorite Compositions with Enhanced Anti-Viral and Anti-Microbial Efficacy and Reduced Toxicityapplication
- Active Agent Delivery Devices and Methods for Using the Sameapplication
- Active Agent Delivery Devices and Methods for Using the Sameapplication
- Therapeutic Agent Delivery Devices Having Integrated Pain Mitigation, and Methods for Using the Sameapplication
- Active Agent Delivery Devices and Methods for Using the Sameapplication
- Active Agent Delivery Devices And Methods For Using The Sameapplication
- Solid Active Agent Formulation Delivery Devices And Methods For Using The Sameapplication
- Viscous Active Agent Delivery Devices And Methods For Using The Sameapplication
- Subcutaneous Delivery Devices And Methods For Using The Sameapplication
- Active Agent Delivery Devices And Methods For Using The Sameapplication
- Active Agent Delivery Devices And Methods For Using The Sameapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.